Osteoarthritis: A problem of growth not decay?

Rheumatology

Volumn 47, Issue 10, 2008, Pages 1452-1460

  Aspden, R M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Aetiology; Growth; Hypertrophy; Metabolic disease; Osteoarthritis; Systemic disease

Indexed keywords

AGGRECAN; ALPHA CALCITONIN GENE RELATED PEPTIDE; CANNABINOID 1 RECEPTOR; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; COLLAGEN TYPE 2; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUTAMIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MATRILIN 3; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPEPTIDE Y; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEROTONIN; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTHRALGIA; ARTICULAR CARTILAGE; BIOMECHANICS; BONE BLOOD FLOW; BONE DEVELOPMENT; CARTILAGE DEGENERATION; CELL FUNCTION; CYTOKINE PRODUCTION; DRUG MECHANISM; EPIGENETICS; GENE EXPRESSION; GENETIC VARIABILITY; HIP OSTEOARTHRITIS; HUMAN; INFLAMMATION; INTRACTABLE PAIN; JOINT STABILITY; KNEE OSTEOARTHRITIS; MESENCHYME; MUSCLE ATROPHY; NONHUMAN; OBESITY; OSSIFICATION; OSTEOARTHRITIS; OSTEOSCLEROSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

BONE AND BONES; CARTILAGE, ARTICULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JOINT CAPSULE; LIGAMENTS, ARTICULAR; MUSCLE, SKELETAL; OBESITY; OSTEOARTHRITIS;

EID: 52949118540     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken199     Document Type: Review

References (127)

1. Radin EL, Burr DB, Caterson B, Fyhrie D, Brown TD, Boyd RD. Mechanical determinants of osteoarthrosis. Semin Arthritis Rheum 1991;21:12-21.
2. Brandt KD, Radin EL, Dieppe PA, van do Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis 2006;65:1261-4.
3. Gleason SS, Askew R, Sheppard B et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005;434:644-8.
4. Stanton H, Rogerson FM, East CJ et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005;434:648-52.
5. Felson DT, Zhang Y, Hannan MT et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 1995;38:1500-5.
6. Cooper C, Egger P, Coggon D et al. Generalized osteoarthritis in women: Pattern of joint involvement and approaches to definition for epidemiological studies. J Rheumatol 1996;23:1938-42.
7. Hirsch R, Lethbridge-Cejku M, Scott WW Jr et al. Association of hand and knee osteoarthritis: Evidence for a polyarticular disease subset. Ann Rheum Dis 1996;55:25-9.
8. Croft P, Cooper C, Wickham C, Coggon D. Is the hip involved in generalized ostooarthritis? Br J Rheumatol 1992;31:325-6.
9. Hochberg MC, Lane NE, Pressman AR, Genant W, Scott JC, Nevitt MC. The association of radiographic changes of osteoarthritis of the hand and hip in elderly women. J Rheumatol 1996;22:2291-4.
10. Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA. Obesity as a risk factor for osteoarthritis of the hand and wrist: A prospective study. Am J Epidemiol 1994;139:119-29.
11. Hart DJ, Doyle DV, Spector TD. Association between metabolic factors and knee osteoarthritis in women: The Chingford Study. J Rheumatol 1995;22:1118-23.
12. Aspden RM, Scheven BAA, Hutchison JD. Osteoarthritis is a systemic disorder involving stromal cell differentiation and lipid metabolism. Lancet 2001;357:1118-20.
13. Nevitt MC, Lane NE, Scott JC et al. Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. Arthritis Rheum 1995;38:907-16.
14. Balblanc JC, Mathieu P, Mathieu L et al. Progression of digital osteoarthritis: A sequential scintigraphic and radiographic study. Osteoarthritis Cart 1995;3:181-6.
15. Buckland-Wright JC, Macfarlane DG, Lynch JA. Sensitivity of radiographic features and specificity of scintigraphic imaging in hand osteoarthritis. Rev Rhum Engl Ed 1995;62:14S-26S.
16. Mazzuca SA, Brandt KD, Schauwecker DS et al. Bone scintigraphy is not a better predictor of progression of knee asteosarthritis than Kellgren and Lawrence grade. J Rheumatol 2004;31:329-32.
17. Li B, Marshall D, Roe M, Aspden RM. The electron-microscope appearance of the subchondral bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999;195:101-10.
18. Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KPH. Subchondral bone in osteoarthritis. Calcif Tissue Int 1991;49:20-6.
19. Li B, Aspdon RM. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 1997;12:641-51.
20. Li B, Aspden RM. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997;56:247-54.
21. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 2001;16:1015-27.
22. Gevers G, Dequeker J, Geusens P, Nyssen-Behets C, Dhem A. Physical and histomorphoiogical characteristics of iliac crest bone differ according to the grade of osteoarthritis at the hand. Bone 1989;10:173-7.
23. Gevers G, Dequeker J, Martens M, Van AR, Nyssen-Behets C, Dhem A. Biomechanical characteristics of iliac crest bone in elderly women according to osteoarthritis grade at the hand joints. J Rheumatol 1989;16:660-3.
24. Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor β in cortical bone from the iliac crest. Arthritis Rheum 1993;36:1702-8.
25. Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 2004;35:334-42.
26. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 2007;38:151-6.
27. Sanchez C, Deberg MA, Bellahcene A et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 2008;58:442-55.
28. Hilal G, Martel-Pelletier J, Pelletier J-P, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: Possible role in subchondral bone sclerosis. Arthritis Rheum 1998;41:891-9.
29. Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 2006;8:R177.
30. Massicotte F, Lajeunesse D, Benderdour M et al. Can altered production of interleukin-1 beta, interieukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthr Cartilage 2002;10:491-500.
31. Paredes Y, Massicotte F, Pelletier JP, Martel-Pelletier J, Laufer S, Lajeunesse D. Study of the role of leukotriene B4 in abnormal function of human subchondral osteoarthritis osteoblasts: Effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum 2002;46:1804-12.
32. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; CD001160.
33. Beck A, Salem K, Krischak G, Kinzi L, Bischoff M, Schmalz A. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the perioperative phase in traumatology and orthopedics effects on bone healing. Oper Orthop Traumatol 2005;17:569-78.
34. Aspden RM, Hochet X. Wnt signalling in osteoarthritic bone. Osteoarthr Cartilage 2006;14:S275.
35. McCauley TR, Komaat PR, Jee WH. Central osteophytes in the knee: prevalence and association with cartilage defects on MR imaging. Am J Roentgenol 2001;176:359-64.
36. Gelse K, Soder S, Eger W, Diemtar T, Aigner T. Osteophyte development-molecular characterization of differentiation stages. Osteoarthr Cartilage 2003;11:141-8.
37. van der Kraan PM, van den Berg WO. Osteophytes: Relevance and biology. Osteoarthr Cartilage 2007;15:237-44.
38. van Beuningan HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
39. Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002;169:507-14.
40. Dedrick DK, Goldstein SA, Brandt KD, O'Connor BL, Goulet RW, Albrecht M. A longitudinal study of subchondral plate and trabecular bone in cruciate deficient dogs with osteoarthritis followed up for 54 months. Arthritis Rheum 1993;36:1460-7.
41. Burr DB. The importance of subchondral bone in osteoarthresis. Curr Opin Rheumatol 1998;10:256-62.
42. Havdrup T, Hulth A, Telhag H. The subchondral bone in osteoarthritis and rheumatoid arthritis of the knee. A histological and microradiographical study. Acta Orthop Scand 1976;47:345-50.
43. Landells JW. The bone cysts of osteoarthritis. J Bone Joint Surg Br 1953; 35-B:643-9.
44. Rhaney K, Lamb DW. The cysts of ostecarthritis of the hip; a radiological and pathological study. J Bone Joint Surg Br 1955;37-B:663-75.
45. Carrino JA, Blum J, Parellada JA, Schweitzer ME, Morrison WB. MRI of bone marrow edema-like signal in the pathogenesis of subchondral cysts. Osteoarthr Cartilage 2006;14:1081-5.
46. Taljanovic MS, Graham AR, Benjamin JB et al. Bone marrow edema pattern in advanced hip osteoarthritis: Quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathotogy. Skeletal Radiol 2008;37:423-31.
47. Gregory JS, Waarsing JH, Day JS et al. Early identification of radiographic osteoarthritis of the hip using an active shape model to quantify changes in bone morphometric features: Can hip shape tell us anything about the progression of osteoarthritis? Arthritis Rheum 2007;56.3634-43.
48. Ralphs JR, Benjamin M. The joint capsule: Structure, composition, ageing and disease. J Anal 1994;184:503-9.
49. Lloyd-Roberts GC. The role of capsular changes in osteoarthritis of the hip joint. J Bone Joint Surg Br 1953;35-B:627-42.
50. Hill CL, Seo GS, Gale D, Totterman S, Gale ME, Felson DT. Cruciate ligament integrity in osteoarthritis of the knee. Arthritis Rheum 2005;52:794-9.
51. Anderson-MacKenzie JM, Billingham ME, Bailey AJ. Collagen remodeling in the anterior cruciate ligament associated with developing spontaneous murine osteoarthritis. Biochem Biophys Res Commun 1999;258:763-7.
52. Roach HI, Aigner T, Soder S, Haag J, Welkerling H. Pathobiology of osteoarthritis: Pathomechanisms and potential therapeutic targets. Curr Drug Targets 2007; 8:271-82.
53. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007;213:626-34.
54. Haywood L, McWilliams DF, Pearson CI et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003;48:2173-7.
55. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology 2005;44:7-16.
56. Jones EA, English A, Henshaw, K et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50:817-27.
57. De Bari C, Pringle S, Pitzalis C, Dell'Accio F. The stem cell niche: A new target in medicine. Curr Opin Orthoped 2006;17:398-404.
58. Nordesjö LO, Nordgren B, Wigren A, Kolsted K. Isometric strength and endurance in patients with severe rheumatoid arthritis or osteoarthrosis in the knee joints. A comparative study in healthy men and women. Scand J Rheumatol 1983;12:152-6.
59. Ekdahl C, Andersson SI, Svensson B. Muscle function of the lower extremities in rheumatoid arthritis and osteoarthrosis. A descriptive study of patients in a primary health care district. J Clin Epidemiol 1989;42:947-54.
60. Brandt KD. Neuromuscular aspects of osteoarthritis: A perspectiva. Novartis Found Symp 2004;260:49-58.
61. Sirca A, Susec-Michieli M. Selective type II fibre muscular atrophy in patients with osteoarthrits of the hip. J Neurol Sci 1980;44:149-59.
62. Hurley MV, The role of muscle weakness in the pathogenesis of osteoarthritis. Rheum Dis Clin North Am 1999;95:283-98.
63. Slemenda C, Brandt KD, Heilman DK et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med 1997;127:97-104.
64. Brandt KD, Heilman DK, Slemenda C et al. Quadriceps strength in women with radiographically progressive osteoarthritis of the knee and those with stable radiographic changes. J Rheumatol 1999;26:2431-7.
65. Stemenda C, Heilman DK, Brandt KD et al. Reduced quadriceps strength relative to body weight: A risk factor for knee ostsoarthritis in woman? Arthritis Rheum 1998;41:1951-9.
66. Roubenoff R. Sarcopenic obesity: Does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 2000;904:553-7.
67. Nakamura T, Suzuki K. Muscular changes in osteoarthritis of the hip and knee. Nippon Seikelgeka Gakkai Zasshi 1992;66:467-75.
68. Fink B, Egl M, Singer J, Fuerst M, Bubenheim M, Nouen-Jacob E. Morphologic changes in the vastus medialis muscle in patients with osteoarthrffis of the knee. Arthritis Rheum 2007;56:3626-33.
69. Sharma L. Proprioception in osteoarthritis. In: Brandt KD, Doherty M, Lohmandar LS, eds. Osteoarthritis. Oxford: Oxford University Press, 2003:172-7.
70. Woolf AD, Breedveld F, Kvien TK. Controlling the obesity epidemic is important for maintaining musculoskeleta) health. Ann Rheum Dis 2006;65:1401-2.
71. Pottie P, Presle N, Terlain B, Netter P, Mainard D, Berenbaum F. Obesity and osteoarthritis: More complex than predicted! Ann Rheum Dis 2006;65:1403-5.
72. Felson DT, Lawrence RC, Dieppe PA et al. Osteoarthritis: New insights. Part 1: The disease and its risk factors. Ann Intern Med 2000;133:635-46.
73. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthrttis. The Framingham Study. Ann Intern Med 1988;109:18-24.
74. Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: The Chingford Study. Arthritis Rheum 1999;42:17-24.
75. Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology 1999;10:161-6.
76. Cornish J, Callon KE, Bava U et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002;175:405-15.
77. Dumond H, Presle N, Teriain B et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003;48:3118-29.
78. Ducy P, Arnling M, Takeda S et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000;100:197-207.
79. Lajeunesse D, Pelletier JP, Martel-Pelletier J. Osteoarthritis: A metabolic disease induced by local abnormal leptin activity? Curr Rheumatol Rep 2005;7:79-81.
80. Ehling A, Schaffer A, Herfarth H et al. The potential of adiponectin in driving arthritis. J Immunol 2006;176:4468-78.
81. Toda Y, Toda T, Takemura S, Wada T, Morimoto T, Ogawa R. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998;25:2181-6.
82. Plumb MS, Aspden RM. High levels of fat and (n-6) fatty acids in cancellous bone in osteoarthritis. Lipid Health Dis 2004;3:12.
83. Marks R, Allegrante JP. Comorbid disease profiles of adults with end-stage hip osteoarthritis. Med Sci Monit 2002;8:CR305-9.
84. Parhami F, Tintut Y, Patel JK, Mody N, Hemmet A, Demer LL. Regulation of vascular calcification in atherosclerosis. Z Kardiol 2001;90(Suppl 3):27-30.
85. Parhami F, Jackson SM, Tintut Y et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999;14:2067-78.
86. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-94.
87. Kidd B. Pathogenesis of joint pain in osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis. Oxford: Oxford University Press, 2003.
88. Suri S, Gill SE, Massena de CS, Wilson D, McWilliams DF, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 2007;66:1423-8.
89. Elefteriou F. Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci 2005;62:2339-49.
90. Patel MS, Elefteriou F. The new field of neuroskeletal biology. Calcif Tissue Int 2007;80:337-47.
91. Brookes M, Helal B. Primary osteoarthritis, venous engorgement and osteogenesis. J Bone Joint Surg Br 1968,50:493-504.
92. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology 2007:46:1763-8.
93. Harrison MHM, Schajowicz F, Trueta J. Osteoarthritis of the hip: A study of the nature and evolution of the disease. J Bone Joint Surg Br 1953;35-B:59B-626.
94. Conaghan PG, Vanharanta H, Dieppe PA. Is progressive osteoarthritis an atheromatous vascular disease? Ann Rheum Dis 2005;64:1539-41.
95. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000;43:1916-26.
96. Aigner T, Glückert K, von der Mark K. Activation of fibrillar oollagen synthesis and phenotypic modulation of chondrocytes in early human osteoarthritic cartilage lesions. Osteoarthr Cartilage 1997;5:183-9.
97. Lohmander LS, Ionescu M, Jugessur H, Poole AR. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum 1999;42:534-44.
98. Aigner T, Zhu Y, Chansky HH, Matsen FA III, Maloney WJ, Sandell LJ. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 1999;42:1443-50.
99. Goldring MB. Osteoarthritis and cartilage: The role of cytokines. Curr Rheumatol Rep 2000;2:459-65.
100. Lippiello, L, Walsh T, Fienhold M. The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 1991;40:571-6.
101. Oettmeier R, Abendroth K, Oettmeier S. Analyses of the tidemark on human femoral heads. II. Tidemark changes in osteoarthrosis-a histological and histomorphometric study in non-decalcified preparations. Acta Morphol Hung 1989;37:169-80.
102. Aspden RM. Fibre reinforcing by collagen in cartilage and soft connective tissues. Proc R Soc Lond 1994;B-258:195-200.
103. Hukins DWL, Aspden RM. Composition and properties of connective tissues. Trends Biochem Sci 1985;10:260-4.
104. Lewis RJ, MacFarland AK, Anandavijayan S, Aspden RM. Site variation of material properties and metabolic activity of articular cartilage from the bovine carpometacarpal joint. Osteoarthr Cartilage 1998;6:383-92.
105. Aspden RM. The theory of fibre reinforced composite materials applied to changes in the mechanical properties of the cervix during pregnancy. J Theor Biol 1988;130:213-21.
106. Plumb MS, Treon KT, Aspden RM. The response of elderly human articular cartilage to mechanical stimuli in vitro and insulin-like growth factor I (IGF-1) in vitro. J Sport Sci 2003;21:330.
107. Jeffrey JE, Thompson LA, Aspden RM. Matrix loss and synthesis following a single impact load on articular cartilage in vitro. Biochim Biophys Acta 1997;1334:223-32.
108. Rodriguez-Lopez J, Mustafa Z, Pombo-Suarez M et al. Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis. Arthritis Rheum 2008;58:435-41.
109. Fosang AJ, Rogerson FM, East CJ, Stanton H. ADAMTS-5: The story so far. Eur Cell Mater 2008;15:11-26.
110. Spector TD, MacGregor AJ. Risk factors for osteoarthritis: Genetics. Osteoarthr Cartilage 2004;12(Suppl A):S39-44.
111. Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med 2005;7:1-12.
112. Chapman K, Takahashi A, Meulenbelt I et al. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5′ UTR of GDF5 with osteoarthritis susceptibility. Hum Mol Genet 2008;17:1497-504.
113. Miyamoto Y, Mabuchi A, Shi D et al. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007;39:529-33.
114. Meulenbelt I, Min JL, Bos S et al. Identification of DIO2 as new susceptibility locus for symptomatic osteoarthritis. Hum Molr Genet. Advance Access published March 11, 2008, doi: 10.1093/hmg/ddn082.
115. Frazer KA, Ballinger DG. Cox DR et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-61.
116. Lumey LH. Decreased birthweights in infants after maternal in utero exposure to the Dutch famine of 1944-1945. Paediatr Perinat Epidemiol 1992;6:240-53.
117. Stein AD, Zybert PA, van der Pal-de Bruin, Lumey LH. Exposure to famine during gestation, size at birth, and blood pressure at age 59 y: evidence from the Dutch Famine. Eur J Epidemiol 2006;21:759-65.
118. Kaati G, Bygren LO, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents 'and grandparents' slow growth period. Eur J Hum Genet 2002;10:682-8.
119. Roach HI, Aigner T. DNA methylation in osteoarthritic chondrocytes: A new molecular target. Osteoarthr Cartilage 2007;15:128-37.
120. Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: Possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007;66:1616-21.
121. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003;113:25-36.
122. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004;432:226-30.
123. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-8.
124. Sokol NS, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005;19:2343-54.
125. Esau C, Davis S, Murray SF et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98.
126. Felson DT. Weight and osteoarthritis. J Rheumatol Suppl 1995;43:7-9.
127. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000;275:721-4.